pembrolizumab
merck
['melsm', 'melanoma', 'pembro']
proud of kari kendra and for #asco22 oral presentation on s1512 neoadj pembro for desmoplastic #melanoma discussant called it a "perfect neoadjuvant study" given the high rate of pathologic response #melsm 
SWOG Melanoma Chair, Med Onc at MD Anderson Cancer Center.  Tweets are my own.